{"pmid":32427416,"title":"COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.","text":["COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.","A patient with coronavirus disease 19 (COVID-19) developed acute myocardial infarction (AMI) complicated by extensive coronary thrombosis and cardiogenic shock. She underwent percutaneous coronary intervention and placement of a mechanical circulatory support device but subsequently died from shock. This report illustrates the challenges in managing patients with COVID-19, AMI, and cardiogenic shock.","Catheter Cardiovasc Interv","Harari, Rafael","Bangalore, Sripal","Chang, Ernest","Shah, Binita","32427416"],"abstract":["A patient with coronavirus disease 19 (COVID-19) developed acute myocardial infarction (AMI) complicated by extensive coronary thrombosis and cardiogenic shock. She underwent percutaneous coronary intervention and placement of a mechanical circulatory support device but subsequently died from shock. This report illustrates the challenges in managing patients with COVID-19, AMI, and cardiogenic shock."],"journal":"Catheter Cardiovasc Interv","authors":["Harari, Rafael","Bangalore, Sripal","Chang, Ernest","Shah, Binita"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427416","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/ccd.28992","keywords":["covid-19","cardiogenic shock","myocardial infarction"],"topics":["Case Report"],"weight":1,"_version_":1667252837931810817,"score":9.490897,"similar":[{"pmid":32473912,"title":"Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic.","text":["Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic.","Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.","Cardiovasc Revasc Med","Chitturi, Kalyan R","Faza, Nadeen N","Little, Stephen H","Kleiman, Neal S","Reardon, Michael J","Goel, Sachin S","32473912"],"abstract":["Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up."],"journal":"Cardiovasc Revasc Med","authors":["Chitturi, Kalyan R","Faza, Nadeen N","Little, Stephen H","Kleiman, Neal S","Reardon, Michael J","Goel, Sachin S"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32473912","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.carrev.2020.05.030","keywords":["covid-19","cardiogenic shock","mitraclip","mitral regurgitation"],"topics":["Prevention"],"weight":1,"_version_":1668341932724584448,"score":274.16843},{"pmid":32275347,"title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock.","text":["Myocardial localization of coronavirus in COVID-19 cardiogenic shock.","We describe the first case of acute cardiac injury directly linked to myocardial localization of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in a 69-year-old patient with flu-like symptoms rapidly degenerating into respiratory distress, hypotension, and cardiogenic shock. The patient was successfully treated with venous-arterial extracorporeal membrane oxygenation (ECMO) and mechanical ventilation. Cardiac function fully recovered in 5 days and ECMO was removed. Endomyocardial biopsy demonstrated low-grade myocardial inflammation and viral particles in the myocardium suggesting either a viraemic phase or, alternatively, infected macrophage migration from the lung.","Eur J Heart Fail","Tavazzi, Guido","Pellegrini, Carlo","Maurelli, Marco","Belliato, Mirko","Sciutti, Fabio","Bottazzi, Andrea","Sepe, Paola Alessandra","Resasco, Tullia","Camporotondo, Rita","Bruno, Raffaele","Baldanti, Fausto","Paolucci, Stefania","Pelenghi, Stefano","Iotti, Giorgio Antonio","Mojoli, Francesco","Arbustini, Eloisa","32275347"],"abstract":["We describe the first case of acute cardiac injury directly linked to myocardial localization of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in a 69-year-old patient with flu-like symptoms rapidly degenerating into respiratory distress, hypotension, and cardiogenic shock. The patient was successfully treated with venous-arterial extracorporeal membrane oxygenation (ECMO) and mechanical ventilation. Cardiac function fully recovered in 5 days and ECMO was removed. Endomyocardial biopsy demonstrated low-grade myocardial inflammation and viral particles in the myocardium suggesting either a viraemic phase or, alternatively, infected macrophage migration from the lung."],"journal":"Eur J Heart Fail","authors":["Tavazzi, Guido","Pellegrini, Carlo","Maurelli, Marco","Belliato, Mirko","Sciutti, Fabio","Bottazzi, Andrea","Sepe, Paola Alessandra","Resasco, Tullia","Camporotondo, Rita","Bruno, Raffaele","Baldanti, Fausto","Paolucci, Stefania","Pelenghi, Stefano","Iotti, Giorgio Antonio","Mojoli, Francesco","Arbustini, Eloisa"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275347","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ejhf.1828","keywords":["cardiac injury","cardiogenic shock","coronavirus","extracorporeal membrane oxygenation","myocardial inflammation","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138491725021184,"score":269.62598},{"pmid":32376532,"pmcid":"PMC7086133","title":"[Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition)].","text":["[Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition)].","The SARS-CoV-2 epidemic starting in Wuhan in December, 2019 has spread rapidly throughout the nation. The control measures to contain the epidemic also produced influences on the transport and treatment process of patients with acute myocardial infarction (AMI), and adjustments in the management of the patients need to be made at this particular time. AMI is characterized by an acute onset with potentially fatal consequence, a short optimal treatment window, and frequent complications including respiratory infections and respiratory and circulatory failure, for which active on-site treatment is essential. To standardize the management and facilitate the diagnosis and treatment, we formulated the guidelines for the procedures and strategies for the diagnosis and treatment of AMI, which highlight 5 Key Principles, namely Nearby treatment, Safety protection, Priority of thrombolysis, Transport to designated hospitals, and Remote consultation. For AMI patients, different treatment strategies are selected based on the screening results of SARS-CoV-2, the time window of STEMI onset, and the vital signs of the patients. During this special period, the cardiologists, including the interventional physicians, should be fully aware of the indications and contraindications of thrombolysis. In the transport and treatment of AMI patients, the physicians should strictly observe the indications for patient transport with appropriate protective measurements of the medical staff.","Nan Fang Yi Ke Da Xue Xue Bao","Bu, Jun","Chen, Mao","Cheng, Xiaoshu","Dong, Yifei","Fang, Weiyi","Ge, Junbo","Gong, Yanjun","He, Ben","Huang, Lan","Huo, Yong","Jia, Shaobin","Jiang, Jun","Li, Yue","Li, Zhao","Liang, Chun","Liu, Xuebo","Liu, Zhenyu","Ma, Xiang","Ma, Yitong","Qian, Juying","Shen, Chengxing","Shen, Difei","Shen, Li","Shi, Ruizheng","Su, Xi","Sun, Yingxian","Tang, Yida","Wang, Jianan","Wu, Yue","Xiang, Dingcheng","Xu, Tongda","Xu, Yawei","Yang, Yuejin","Zeng, Hesong","Zhang, Cheng","Zhang, Guogang","Zhang, Ruiyan","Zhang, Shuning","Zhang, Yun","Zhang, Zheng","Zheng, Bo","Zhou, Ning","32376532"],"abstract":["The SARS-CoV-2 epidemic starting in Wuhan in December, 2019 has spread rapidly throughout the nation. The control measures to contain the epidemic also produced influences on the transport and treatment process of patients with acute myocardial infarction (AMI), and adjustments in the management of the patients need to be made at this particular time. AMI is characterized by an acute onset with potentially fatal consequence, a short optimal treatment window, and frequent complications including respiratory infections and respiratory and circulatory failure, for which active on-site treatment is essential. To standardize the management and facilitate the diagnosis and treatment, we formulated the guidelines for the procedures and strategies for the diagnosis and treatment of AMI, which highlight 5 Key Principles, namely Nearby treatment, Safety protection, Priority of thrombolysis, Transport to designated hospitals, and Remote consultation. For AMI patients, different treatment strategies are selected based on the screening results of SARS-CoV-2, the time window of STEMI onset, and the vital signs of the patients. During this special period, the cardiologists, including the interventional physicians, should be fully aware of the indications and contraindications of thrombolysis. In the transport and treatment of AMI patients, the physicians should strictly observe the indications for patient transport with appropriate protective measurements of the medical staff."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["Bu, Jun","Chen, Mao","Cheng, Xiaoshu","Dong, Yifei","Fang, Weiyi","Ge, Junbo","Gong, Yanjun","He, Ben","Huang, Lan","Huo, Yong","Jia, Shaobin","Jiang, Jun","Li, Yue","Li, Zhao","Liang, Chun","Liu, Xuebo","Liu, Zhenyu","Ma, Xiang","Ma, Yitong","Qian, Juying","Shen, Chengxing","Shen, Difei","Shen, Li","Shi, Ruizheng","Su, Xi","Sun, Yingxian","Tang, Yida","Wang, Jianan","Wu, Yue","Xiang, Dingcheng","Xu, Tongda","Xu, Yawei","Yang, Yuejin","Zeng, Hesong","Zhang, Cheng","Zhang, Guogang","Zhang, Ruiyan","Zhang, Shuning","Zhang, Yun","Zhang, Zheng","Zheng, Bo","Zhou, Ning"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376532","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.02.01","keywords":["myocardial infarction","novel coronavirus pneumonia","protection","thrombolysis","transshipment"],"locations":["Wuhan","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666596532337508352,"score":234.97815},{"pmid":32352633,"title":"Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.","text":["Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.","Important health resources are dedicated worldwide to the management of COVID-19. This new disease, due to its large diffusion, may significantly hamper the prognosis of other pathologies, such as ST-segment elevation myocardial infarction (STEMI) because of (a) a possible direct negative impact and (b) shortage of first response medical resources and increased delays to reperfusion. We report the case of a 68-year-old man admitted for anterior STEMI and asymptomatic COVID-19. Due to extended transportation delays to a cathlab, he received intravenous fibrinolytic therapy, which failed. Reperfusion was achieved with rescue coronary angioplasty, but the patient experienced two episodes of acute stent thrombosis at 2- and 36-hr following admission and despite optimal medical therapy. He finally died because of cardiogenic shock. This raises concerns about a possible increase in platelet aggregability associated with COVID-19 leading to an increased risk of stent thrombosis, particularly in the context of STEMI. This pleads for the promotion of primary coronary angioplasty as the first-choice revascularization technique in this population and the use of new generation P2Y12 inhibitors. In addition, the use of GPIIb/IIIa inhibitors may be considered in every STEMI patient with COVID-19 to prevent the risk of acute stent thrombosis.","Catheter Cardiovasc Interv","Lacour, Thibaud","Semaan, Carl","Genet, Thibaud","Ivanes, Fabrice","32352633"],"abstract":["Important health resources are dedicated worldwide to the management of COVID-19. This new disease, due to its large diffusion, may significantly hamper the prognosis of other pathologies, such as ST-segment elevation myocardial infarction (STEMI) because of (a) a possible direct negative impact and (b) shortage of first response medical resources and increased delays to reperfusion. We report the case of a 68-year-old man admitted for anterior STEMI and asymptomatic COVID-19. Due to extended transportation delays to a cathlab, he received intravenous fibrinolytic therapy, which failed. Reperfusion was achieved with rescue coronary angioplasty, but the patient experienced two episodes of acute stent thrombosis at 2- and 36-hr following admission and despite optimal medical therapy. He finally died because of cardiogenic shock. This raises concerns about a possible increase in platelet aggregability associated with COVID-19 leading to an increased risk of stent thrombosis, particularly in the context of STEMI. This pleads for the promotion of primary coronary angioplasty as the first-choice revascularization technique in this population and the use of new generation P2Y12 inhibitors. In addition, the use of GPIIb/IIIa inhibitors may be considered in every STEMI patient with COVID-19 to prevent the risk of acute stent thrombosis."],"journal":"Catheter Cardiovasc Interv","authors":["Lacour, Thibaud","Semaan, Carl","Genet, Thibaud","Ivanes, Fabrice"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352633","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ccd.28948","keywords":["acute myocardial infarction","antithrombotic treatment","viral infection"],"topics":["Case Report"],"weight":1,"_version_":1666138495758893056,"score":230.2402},{"pmid":32470162,"title":"Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.","text":["Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.","The coronavirus disease-2019 (COVID-19) is a viral illness with heterogenous clinical manifestations, ranging from mild symptoms to severe acute respiratory distress syndrome and shock caused by the severe acute respiratory syndrome coronavirus-2. The global healthcare community is rapidly learning more about the effects of COVID-19 on the cardiovascular system, as well as the strategies for management of infected patients with cardiovascular disease. There is minimal literature available surrounding the relationship between COVID-19 infection and acute coronary syndrome. We describe the case of a woman who presented with an acute anterior ST-elevation myocardial infarction managed by primary percutaneous coronary intervention, who subsequently developed severe COVID-19 infection and ultimately succumbed to multisystem organ failure.","Catheter Cardiovasc Interv","Rothstein, Eric S","Welch, Terrence D","Andrus, Bruce W","Jayne, John E","32470162"],"abstract":["The coronavirus disease-2019 (COVID-19) is a viral illness with heterogenous clinical manifestations, ranging from mild symptoms to severe acute respiratory distress syndrome and shock caused by the severe acute respiratory syndrome coronavirus-2. The global healthcare community is rapidly learning more about the effects of COVID-19 on the cardiovascular system, as well as the strategies for management of infected patients with cardiovascular disease. There is minimal literature available surrounding the relationship between COVID-19 infection and acute coronary syndrome. We describe the case of a woman who presented with an acute anterior ST-elevation myocardial infarction managed by primary percutaneous coronary intervention, who subsequently developed severe COVID-19 infection and ultimately succumbed to multisystem organ failure."],"journal":"Catheter Cardiovasc Interv","authors":["Rothstein, Eric S","Welch, Terrence D","Andrus, Bruce W","Jayne, John E"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470162","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ccd.28967","keywords":["sars-cov-2","cytokine storm","myocardial infarction","revascularization"],"locations":["USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1668420887263576064,"score":217.39786}]}